Novotech

About

Novotech is a full‑service clinical research organization providing integrated services to biotech and pharma, specializing in cell and gene therapies, radiopharmaceuticals, mRNA and multi‑region trials across APAC, US, Europe.

Mission

Novotech is a full-service clinical research organization focused on biotech and small- to mid-sized pharma customers, with particular expertise in cell and gene therapies, radiopharmaceuticals and mRNA trials. Headquartered in Singapore, the company has a global footprint with 30+ offices across APAC, North America and Europe and partnerships with 5,000+ trial sites. Novotech reports roughly 3,000 employees and experience across more than 6,000 clinical projects. The firm offers integrated people, processes and technologies to accelerate drug development and claims a long track record of industry recognition, including consecutive Frost & Sullivan CRO Company of the Year awards. Management says new capital will be used to pursue further organic growth, targeted expansion in the US and Europe, and transformative M&A as the industry consolidates. The company aims to become the first truly global biotech‑focused CRO and to win a growing share of larger multi-region trials, particularly those with a center of gravity in Asia.

Quick Facts